Início › Câncer de Próstata › Massachusetts
Ensaios clínicos de Câncer de Próstata em Massachusetts
66 estudos para Câncer de Próstata estão buscando participantes em locais em Massachusetts.
Cidades em Massachusetts
Texto oficial do estudo (Inglês)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750Distance-Based Exercise to Preserve Function and Prevent Disability
- Dana-Farber Cancer Institute, Boston
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07059884A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Massachusetts General Hospital, Boston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06465069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Dana-Farber Cancer Institute at Foxborough, Foxborough
- Dana Farber-Merrimack Valley, Methuen
- Dana-Farber/Brigham and Women's Cancer Center at Milford Regional, Milford
- e mais 2
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Lahey Clinic, Burlington
- Lahey Clinic Peabody, Peabody
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT03866382Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
- Massachusetts General Hospital, Boston
RecrutandoFase 4
Idades 18 e acima · Homens · Atualizado em 29 de set. de 2026 · NCT07569926Precision-Based Genomics in Prostate Cancer
- Dana Farber Cancer Institute, Boston, MA, Boston
RecrutandoEstudo observacional
Idades de 18 a 120 · Homens · Atualizado em 28 de set. de 2026 · NCT04706663Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
- Dana Farber Cancer Institute, Boston
Recrutando
Idades 18 e acima · Homens · Atualizado em 28 de set. de 2026 · NCT06496256A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
- Greater Boston Urology, Plymouth
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 25 de set. de 2026 · NCT07832292Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Research Site, Boston
RecrutandoFase 1/2
Idades de 18 a 130 · Homens · Atualizado em 25 de set. de 2026 · NCT07181161Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Dana Farber Mass General Brigham Cancer Care Inc, Boston
RecrutandoFase 1/2
Idades 18 e acima · Homens · Atualizado em 25 de set. de 2026 · NCT06800313Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- Harvard Medical School-Massachusetts General Hospital, Boston
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 25 de set. de 2026 · NCT06801236Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes
- Dana-Farber Cancer Institute, Boston
Recrutando
Idades 18 e acima · Homens · Atualizado em 25 de set. de 2026 · NCT07729150A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 24 de set. de 2026 · NCT07719361Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Dana Farber Cancer Institute, Boston
- Beth Israel Deaconess Medical Center, Boston
RecrutandoFase 2/3
Idades de 18 a 100 · Homens · Atualizado em 22 de set. de 2026 · NCT06780670A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
- Mass General Hospital, Boston
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 22 de set. de 2026 · NCT07570979A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07114601Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Beth Israel Deaconess Med Center, Boston
- Dana Farber Cancer Institute, Boston
RecrutandoFase 3
Idades de 18 a 100 · Homens · Atualizado em 22 de set. de 2026 · NCT06855277CV CARE: CardioVascular Care in PC Patients
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Recrutando
Idades 18 e acima · Homens · Atualizado em 22 de set. de 2026 · NCT06202820A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Plymouth
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 18 de set. de 2026 · NCT06952803A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Beth Israel Deaconess Medical Center ( Site 0043), Boston
- Dana Farber Cancer Institute ( Site 0012), Boston
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 17 de set. de 2026 · NCT06925737A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Dana-Farber Cancer Institute, Boston
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 15 de set. de 2026 · NCT07581184Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Dana-Farber/Brigham and Women's Cancer Center at Milford Regional, Milford
- e mais 1
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 10 de set. de 2026 · NCT05946213Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
- Beth Israel Deaconess Medical Center, Boston
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Recrutando
Idades 18 e acima · Homens · Atualizado em 10 de set. de 2026 · NCT06040125Serial MRI Scans During Radiation Therapy
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT04188535Prostate Active Surveillance Study
- Beth Israel Deaconess Medical Center/Harvard Medical School, Boston
RecrutandoEstudo observacional
Idades 21 e acima · Homens · Atualizado em 2 de set. de 2026 · NCT00756665A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
- Dana Farber Cancer Institute, Boston
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 21 de ago. de 2026 · NCT06844383Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
- Brigham and Women's Hospital, Boston
RecrutandoFase 2
Idades 40 e acima · Homens · Atualizado em 17 de ago. de 2026 · NCT06957691FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05919264Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- Dana-Farber Cancer Institute / Beth Israel Deaconess Medical Center, Boston
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 14 de ago. de 2026 · NCT04812366Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Boston
RecrutandoFase 1/2
Idades de 18 a 130 · Todos os sexos · Atualizado em 12 de ago. de 2026 · NCT05417594A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Dana-Farber Cancer Institute, Boston
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 10 de ago. de 2026 · NCT06067841RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Dana-Farber Cancer Institute at Foxborough, Foxborough
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 30 de jul. de 2026 · NCT05765500Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
- Dana Farber Cancer Institute, Boston
Recrutando
Idades 18 e acima · Homens · Atualizado em 29 de jul. de 2026 · NCT05327465PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
- Dana-Farber Cancer Institute, Boston
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 22 de jul. de 2026 · NCT06274047Jump: MR Simulation For Radiation Therapy Master Protocol
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 20 de jul. de 2026 · NCT04545957Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
- Dana Farber Cancer Institute, Boston
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 2 de jul. de 2026 · NCT07140900Integrated Cancer Repository for Cancer Research
- Holyoke Medical Center, Holyoke
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
- Dana Farber Cancer Institute, Boston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 8 de jun. de 2026 · NCT04890613Androgen-responsive POSLUMA-guided Intra-prostatic Boost
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
- Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center, Milford
- e mais 1
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 29 de mai. de 2026 · NCT07393867Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.